F. Edmondson
General Counsel bei ZAI LAB LIMITED
Vermögen: 446 847 $ am 31.03.2024
Profil
F.
Ty Edmondson is currently the Chief Legal Officer at Zai Lab Ltd.
Prior to this role, he held positions at Sumitomo Pharma America, Inc. as Secretary, Associate General Counsel & VP, and at Biogen, Inc. as Chief Corporation Counsel & Senior Vice President.
He completed his undergraduate degree at Washington & Lee University in 1988 and his graduate degree at Widener University School of Law in 1993.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZAI LAB LTD.
0,03% | 04.04.2024 | 271 102 ( 0,03% ) | 446 847 $ | 31.03.2024 |
Aktive Positionen von F. Edmondson
| Unternehmen | Position | Beginn |
|---|---|---|
| ZAI LAB LIMITED | General Counsel | 07.08.2020 |
Ehemalige bekannte Positionen von F. Edmondson
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01.08.2020 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Secretary | - |
Ausbildung von F. Edmondson
| Washington & Lee University | Undergraduate Degree |
| Widener University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
